Media Posts
OUR PROGRESS IN JUNE 2026
October 12, 2026
WP8 Development of Network Activities
Welcome to the June 2026 edition of the EUnetCCC WP8 newsletter!
June brought WP8 teams together around shared practice. Cancer centre leaders met in Oslo to launch our first governance-focused network, the Guidelines Exchange Program was reshaped into a multi-centre format and teams advanced work on prevention hubs, caregiver pathways, survivorship screening and molecular tumour board data. Research nurses were again in focus as the Clinical Trials task opened a new round of exchanges.
Read on for the latest updates from across WP8.
Task 8.2.1 Guidelines
Guidelines Exchange Program moves to a multicentre approach.
The EUnetCCC Guidelines Exchange Program continues to evolve to strengthen collaboration and peer learning across participating centres. Following a review of applications and further development of the programme, the exchange format has been adapted from a bilateral model to a multi-centre approach, bringing together several centres within a single exchange visit.
This updated format aims to broaden the sharing of experiences, promote mutual learning and create a more sustainable and efficient framework for collaboration.
During autumn 2026, two exchange programme events are planned, each bringing together representatives from 4-6 centres to facilitate knowledge exchange, discussion of challenges and best practices and collaboration on the implementation and follow up of clinical guidelines. Participating centres have recently received a draft discussion guide outlining proposed topics and questions for the joint exchange meetings.
The guide serves as a starting point for shaping the programme collaboratively and centres are invited to contribute suggestions, feedback and additional discussion topics.
Ongoing activities within the Guidelines Core Team: the team continues to advance work on quality indicators, collaboration with medical societies and patient organisations and the exchange of best practices among Comprehensive Cancer Centres.
Patient engagement activities are being further strengthened through planned meetings with patient organisations during autumn 2026. Preparations also continue for the Core Team Guidelines meeting in Ljubljana on 17-18 September.
Task 8.2.2 Personalized Cancer Prevention
Advancing the Cancer Prevention Hub model and caregiver pathways
In June, Task 8.2.2 continued to advance the development of the Cancer Prevention Hub concept, with a focus on integrating prevention into hospital-based cancer care and strengthening links with Comprehensive Cancer Centres.
The team continued work on the Prevention Hubs article framework, with partners invited to provide comments, names and affiliations by the end of the month. This article is expected to be the first publication developed on behalf of the Prevention task and will support the dissemination of the task's conceptual and practical work.
A key focus this month was the role of informal caregivers in prevention. Centre Léon Bérard presented its structured caregiver pathway, developed within the PREVCARE EU project, including three main steps: identification, preventive assessment and consultations and follow-up and guidance. The pathway recognises informal caregivers as full partners in care, while also addressing their own prevention needs and exposure to risk factors such as stress, burnout, anxiety, isolation, tobacco, alcohol, diet, physical inactivity, sun exposure and air pollution.
In parallel, the task discussed stronger collaboration with the Survivorship task after the summer break, to explore commonalities between Prevention Hubs and Survivorship Hubs. This collaboration will help identify shared objectives, practical links between the two models and possible ways to support hospitals in implementing prevention and survivorship activities together.
Task 8.2.5 Secondary Use of Clinical Data
Collaboration and alignment across European data initiatives
At the NOPHO Annual Meeting in Kaunas on 22-25 May, we had the privilege of presenting the work carried out within the Childhood Cancer Equity collaboration initiative. This initiative aligns closely with NOPHO's ongoing efforts and it was a valuable opportunity to be part of the meeting.
Representatives from the 8.2.5 lead team attended the CANDLE Annual Meeting in Lisbon on 1-3 June, to stay informed about developments related to the National Cancer Data Nodes (NCDNs) and to ensure alignment with our strategies for improving data readiness for the secondary use of clinical data across the network of CCCs, which are expected to play a key role as contributors to NCDNs.
Task 8.2.5 has also been actively involved in planning and organising the workshop "Data Collection from Molecular Tumour Board Operations", held in Oslo on 15-16 June in collaboration with Task 8.2.4. The workshop brought together stakeholders from several European initiatives and joint actions to address the flow of data into and out of molecular tumour boards, including follow-up data on outcomes. Task 8.2.5 aims to contribute to the development of standards for the harmonised capture of key elements of these datasets, enabling their secondary use in governance, quality assessment and research within and across CCCs.
On 9 June, we convened a joint meeting bringing together both our core group and participants group to review and reflect on the progress achieved so far within Task 8.2.5.
Task 8.2.6 Clinical Trials
New exchanges, expert insights and patient-focused progress
The Clinical Trials Task has opened a call for interest for the second wave of its Exchange Programme, further strengthening collaboration and knowledge sharing across centres. This new round will bring participants to leading institutions in Luxembourg (focused on regulatory challenges and cross-border access), Spain (academic clinical trials and cooperative groups) and France (early-phase clinical trials), with visits scheduled for September and November 2026. The outcomes of the call for interest will be shared with our network soon.
On 25 June, the task hosted the second session in its thematic series on Research Nurses in Clinical Trials, focusing on the evolving demands of research nursing from early-phase trial complexity to education and career development. Alessandro Brero (Candiolo Cancer Institute IRCCS-FPO, Italy) highlighted the high-intensity environment of Phase I trials, where research nurses play a central role in patient safety, strict protocol adherence and precise, time-sensitive procedures. Helene Sjöö (Karolinska Trial Alliance, Sweden) explored pathways into research nursing, emphasising the need for a strong combination of clinical expertise and research-specific competencies, as well as current challenges linked to training, documentation and balancing clinical and research responsibilities. Together, the presentations underscored the critical role of research nurses in bridging clinical care and research.
Work has also progressed on patient involvement, with a clear focus now defined on improving how patients can access information on ongoing and upcoming clinical trials across Europe. Key priorities include identifying and leveraging existing platforms such as CTIS, developing patient-friendly materials and building a structured repository of trials drawing on European, national, institutional and patient-organisation initiatives.
Task 8.2.7 Cancer Survivorship
Advancing survivorship screening and preparing for Brussels
In June, Task 8.2.7 continued to advance its work on the development and implementation of survivorship care across Comprehensive Cancer Centres, with a strong focus on preparing the upcoming in-person meeting in Brussels on 17-18 September. The Brussels meeting will focus on screening as one important component of survivorship care, while also addressing the broader implementation framework for Survivorship Hubs, including coordination, multidisciplinary care and practical integration into cancer centre structures.
Several Thematic Working Groups continued preparing content for Brussels. TWG 1.1 focused on integrative supportive care, especially nutrition screening tools such as MST, MUST, NRS 2002 and PG-SGA and discussed how these tools could be adapted depending on the resources available in each cancer centre. The group also started preparing next steps on rehabilitation, prehabilitation and physical activity tools. TWG 2 continued its work on psycho-oncological screening and psychoeducation, discussing the Distress Thermometer as a possible basic screening tool, referral pathways after screening, timing of screening and the need for a flexible pool of evidence-based psychoeducational and psychological support activities. TWG 3 and 4 continued work on social care screening templates and gap analysis.
The task also progressed on planning the Survivorship session for the EUnetCCC Annual Meeting in Lisbon, discussing the proposed format and speaker structure and how to present the Survivorship task in a practical and attractive way. The session is expected to include a short introduction by the task lead, a patient representative and CCC representatives actively involved in the task. The team also highlighted the importance of future collaboration with Task 8.2.2 Prevention, especially regarding possible commonalities between Survivorship Hubs and Cancer Prevention Hubs.
Task 8.2.8 Governance of CCCs
The conversations CCC leaders need
"These conversations are exactly what this network is for."
This comment, from one of the attendees of the two-day Governance workshop hosted in Oslo in June, captures the purpose and the fruitful outcome of the event.
Cancer centre leaders from across Europe came together to discuss the organisational and leadership challenges facing Comprehensive Cancer Centres, with focused discussions on patient pathway integration, integrating research and care, integrated data flows and developing a CCC Board. The workshop theme was "Overcoming the Challenges of Lateral Governance of CCCs" and the event marked the launch of EUnetCCC's first governance-focused network of CCC leaders.
Participants shared specific challenges and drew on the collective experience of their peers to help move them forward. It was an intensive couple of days for organisers, facilitators and participants, but the feedback has been warm and very positive, with attendees commenting on the "rich and inspiring exchanges" and "open and generous knowledge sharing".
The workshop was hosted by Oslo University Hospital, which leads the Governance, Organisation and Leadership task in EUnetCCC, together with BI Norwegian Business School as academic advisers.

Task 8.3 Dissemination & Evaluation
A new home for patient involvement on the WP8 website
Task 8.3 has launched a new Patient Involvement page on the WP8 website, bringing together in one place how patients, survivors, caregivers and professionals can take part in the work of EUnetCCC.
The page opens with voices from the patient community, a short video in which patients and survivors share in their own words what it means to be heard and to help shape cancer care.
Alongside the video, the page explains why lived experience is essential expertise, sets out the principles guiding meaningful involvement and shows how it works at every level. A dedicated Get involved form welcomes anyone who would like to contribute, while a growing resources hub gathers frameworks, tools, training materials and good practice examples from across the network.

Visit Patient Involvement Page.
UPCOMING EVENTS
September 17-18, 2026 Task 8.2.1 | Guidelines Core Team meeting
Working meeting and workshop for the Guidelines Core Team.
Onkološki inštitut Ljubljana, Slovenia
September 17-18, 2026 Task 8.2.7 | Cancer Survivorship teaming activity
Day one focuses on screening concepts, working group discussions and practical examples. Day two is dedicated to the broader survivorship implementation framework.
Saint-Luc Hospital, Brussels
September 24-25, 2026 Task 8.2.4 | Precision Diagnostics
Molecular Tumour Board (MTB) Summit 2026
In-person event bringing together experts from across Europe to explore how molecular tumour boards can strengthen precision cancer care, support collaboration and improve equitable patient access.
Rome, Italy
Autumn 2026 Task 8.2.1 | Guidelines Exchange Program visits
Two exchange events, each bringing together representatives from 4-6 centres for knowledge exchange, discussion of challenges and best practices and collaboration on implementing and following up clinical guidelines.
On site, location to be decided
MISSED THE PREVIOUS 2026 EDITIONS? CHECK THEM HERE:
Read the January Newsletter
Read the February Newsletter
Read the March Newsletter
Read the April Newsletter
Read the May Newsletter